# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benny Leonard (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX008-SYN
- Date: 2026-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Miriam Okafor-Rosenthal, MD
- Calendar frame: modern shifted

## What we are working on

- Breathless and tight in the chest late in long nights in the ring, and told his blood pressure is high **S**
- He needs his refereeing work and is afraid of losing his license **S**
- Worry about money since losing his savings years ago, and about the cost of medicines **S**

## Your goals

- Find the cause of the exertional breathlessness and chest tightness. Target: 2026-05-26. Recorded outcome: No inducible ischemia; symptoms from hypertensive heart disease with an exaggerated blood pressure response. **S**
- Blood pressure below 130/80 mmHg at home and in the clinic. Target: 2026-08-25. Recorded outcome: 164/100 at intake to 124/78 in the clinic, home average 122/76 mmHg. **S**
- LDL below 70 mg/dL and at least 50% lower than at intake. Target: 2026-07-28. Recorded outcome: LDL 160 to 66 mg/dL (59% lower) on atorvastatin 40 mg. **S**
- Keep refereeing full cards safely, without symptoms. Target: 2027-05-12. Recorded outcome: Back to full cards after the blood pressure fell; no symptoms since; a week off after the sick visit. **S**
- Regression of left ventricular hypertrophy on a repeat echocardiogram. Target: 2027-05-26. Recorded outcome: Repeat echocardiogram due six to twelve months after the first. **S**

## What we agreed to do

- High blood pressure: home monitoring with a validated upper-arm cuff, twice a day, with readings sent in weekly; single-pill losartan 50 mg with hydrochlorothiazide 12.5 mg from today, chosen as two first-line drugs for stage 2 hypertension and a low-cost generic; basic metabolic panel in two weeks; target below 130/80 mmHg; less salt (no more than 1,500 to 2,300 mg a day), the DASH pattern, and regular walking. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026) **S**
- Cardiology consultation for exertional breathlessness and chest tightness with left ventricular hypertrophy on the ECG: the cause, the type of hypertrophy, sudden cardiac death risk, coronary risk testing, and whether he can keep refereeing. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021) **S**
- Evaluation at intake: resting ECG, basic metabolic panel, TSH, HbA1c, lipid panel, one-time lipoprotein(a) and urine albumin-to-creatinine ratio; stop and rest, and call the same day for chest discomfort at rest or lasting more than a few minutes, fainting or palpitations; referee only short undercards until the consultation. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026) **S**
- Atorvastatin 40 mg each evening after a coronary calcium score of 186, aiming for LDL below 70 mg/dL and at least a 50% fall, with a lipid panel at eight to twelve weeks; aspirin discussed and not started while blood pressure is uncontrolled, to be revisited. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026); 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (2019) **S**
- Return to work: short undercards until home blood pressure is below 140/90 mmHg, then full cards; drink water between bouts in hot arenas; stop and hand over the bout for chest discomfort, faintness or palpitations; hold the blood pressure tablet on sick days (vomiting, diarrhea, or unable to drink) and call; the venue to keep a defibrillator at ringside with staff trained in CPR; repeat echocardiogram in six to twelve months. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (2015) **S**
- Losartan 100 mg with hydrochlorothiazide 25 mg each morning; basic metabolic panel two weeks after the increase. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026) **S**
- Volume depletion: oral fluids with salt and potassium-rich foods; hold losartan-hydrochlorothiazide until the recheck in one week; no refereeing until then; emergency care for fainting or chest pain. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025) **S**
- Change to losartan 100 mg and amlodipine 5 mg each morning, without the thiazide, because of heavy sweating in hot arenas; basic metabolic panel in four weeks; written sick-day rules on a card for his wallet. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026) **S**
- Money worries and mood: PHQ-9 and GAD-7 at intake and at six months; generic once-daily medicines at the lowest cost; a social needs screen; brief support and problem-solving at each visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); Anxiety Disorders in Adults: Screening (2023) **S**

## Follow-up

- 2026-05-12: Establishing primary care at 50 after a referee's license examination found high blood pressure: exertional breathlessness and chest tightness while refereeing, an ECG showing left ventricular hypertrophy, cardiovascular risk, money worries and mood, and a cardiology consultation **S**
- 2026-05-26: Two-week review on the day of the cardiology consultation: the echocardiogram, stress test and calcium score, home blood pressure, a statin, and refereeing **S**
- 2026-06-30: Seven-week review: home blood pressure, the first weeks back at full cards, symptoms, and a dose increase **S**
- 2026-07-28: Periodic adult preventive visit and recheck after the sick visit **S**
- 2026-08-25: Fifteen-week review: blood pressure after the change of medicine, kidney function and potassium, cholesterol on the statin, and the sick visit **S**
- 2026-10-27: Twenty-four-week review: blood pressure control, symptoms at work, mood and worry, aspirin, and the plan ahead **S**

This teaching document does not replace care from a qualified clinician.
